trending Market Intelligence /marketintelligence/en/news-insights/trending/m6k01c2lw1i1zzm_hdik6a2 content esgSubNav
In This List

CytRx attracts $7M investment

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


CytRx attracts $7M investment

CytRx Corp. has attracted a $7 million investment from certain institutional investors who will buy 5,600,000 shares of the company at $1.25 each.

CytRx intends to use the money for working capital and general corporate purposes, including possible new drug discovery activities and acquisitions or mergers.

The offering is expected to close by May 15 with H.C. Wainwright & Co. acting as the exclusive placement agent.

The company is developing cancer treatments.